Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,044 | 589 | 81.2% |
| Travel and Lodging | $2,566 | 7 | 17.3% |
| Consulting Fee | $150.00 | 1 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69.54 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cyberonics, Inc. | $1,747 | 7 | $0 (2017) |
| Inspire Medical Systems, Inc. | $1,254 | 6 | $0 (2023) |
| EMD Serono, Inc. | $1,211 | 39 | $0 (2024) |
| Biogen, Inc. | $887.62 | 51 | $0 (2024) |
| ABBVIE INC. | $687.30 | 67 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $662.00 | 45 | $0 (2024) |
| UCB, Inc. | $615.24 | 24 | $0 (2024) |
| Amgen Inc. | $545.08 | 28 | $0 (2024) |
| GENZYME CORPORATION | $495.82 | 26 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $463.76 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,130 | 134 | EMD Serono, Inc. ($687.42) |
| 2023 | $3,024 | 97 | Inspire Medical Systems, Inc. ($1,254) |
| 2022 | $834.53 | 48 | ABBVIE INC. ($135.68) |
| 2021 | $582.93 | 22 | HARMONY BIOSCIENCES LLC ($144.65) |
| 2020 | $365.58 | 22 | LivaNova USA, Inc. ($65.83) |
| 2019 | $2,041 | 105 | Amgen Inc. ($300.63) |
| 2018 | $1,481 | 76 | Biogen, Inc. ($244.78) |
| 2017 | $3,371 | 97 | Cyberonics, Inc. ($1,747) |
All Payment Transactions
601 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Neurology | ||||||
| 12/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $49.10 | General |
| 12/04/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $10.92 | General |
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.71 | General |
| 11/11/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Neurology | ||||||
| 11/07/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: NEUROLOGY | ||||||
| 11/04/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.37 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $45.53 | General |
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Neurology | ||||||
| 10/29/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: EPILEPSY | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Neurology | ||||||
| 10/21/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: Neurology | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Neurology | ||||||
| 10/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $42.60 | General |
| 10/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.60 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 280 | 301 | $159,925 | $41,054 |
| 2022 | 9 | 320 | 340 | $181,040 | $48,555 |
| 2021 | 10 | 401 | 430 | $288,525 | $77,697 |
| 2020 | 10 | 376 | 400 | $238,455 | $60,624 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 21 | 22 | $41,800 | $10,290 | 24.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 18 | 18 | $32,850 | $7,979 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 81 | $21,060 | $6,933 | 32.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 40 | 40 | $25,800 | $4,106 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 70 | $12,250 | $4,025 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 33 | $11,550 | $3,888 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $14,615 | $3,833 | 26.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 22 | 23 | $41,975 | $10,582 | 25.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 18 | 20 | $38,000 | $9,609 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 68 | $17,680 | $5,666 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $18,960 | $5,436 | 28.7% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 43 | 43 | $27,735 | $4,982 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 70 | $12,250 | $4,334 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 34 | $11,900 | $4,216 | 35.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $11,385 | $3,366 | 29.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,155 | $363.08 | 31.4% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 53 | 54 | $98,550 | $24,579 | 24.9% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 42 | 48 | $91,200 | $23,445 | 25.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 73 | 73 | $28,835 | $7,908 | 27.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 111 | $19,425 | $7,004 | 36.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 58 | $15,080 | $5,206 | 34.5% |
| 95800 | Study of sleep patterns, including sleep time | Office | 2021 | 27 | 27 | $17,415 | $3,299 | 18.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $7,425 | $2,498 | 33.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 13 | $4,550 | $1,833 | 40.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $4,680 | $1,358 | 29.0% |
About Dr. Carmen Dohmeier, M.D
Dr. Carmen Dohmeier, M.D is a Neurology healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588620066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carmen Dohmeier, M.D has received a total of $14,830 in payments from pharmaceutical and medical device companies, with $3,130 received in 2024. These payments were reported across 601 transactions from 85 companies. The most common payment nature is "Food and Beverage" ($12,044).
As a Medicare-enrolled provider, Dohmeier has provided services to 1,377 Medicare beneficiaries, totaling 1,471 services with total Medicare billing of $227,929. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Greensboro, NC
- Active Since 04/25/2006
- Last Updated 09/17/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1588620066
Products in Payments
- VNS Therapy (Device) $1,858
- INSPIRE (Device) $1,254
- Aimovig (Biological) $416.02
- ZEPOSIA (Drug) $387.25
- KESIMPTA (Drug) $343.88
- BOTOX (Biological) $325.41
- Briviact (Drug) $307.72
- TYSABRI (Biological) $260.39
- VALTOCO (Drug) $256.92
- VUMERITY (Drug) $254.50
- QULIPTA (Drug) $249.07
- LEMTRADA (Drug) $237.39
- Wakix (Drug) $229.97
- VYEPTI (Biological) $223.18
- MAVENCLAD (Drug) $202.72
- NUPLAZID (Drug) $201.87
- Rebif (Biological) $201.43
- AJOVY (Drug) $193.56
- TECFIDERA (Drug) $188.88
- AUBAGIO (Drug) $186.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Greensboro
Dr. Pramodkumar Sethi, M.d, M.D
Neurology — Payments: $69,973
Yijun Yan, Md, MD
Neurology — Payments: $12,473
Dr. Adam Jaffe, D.o, D.O
Neurology — Payments: $10,635
Saima Athar, M.d, Phd, M.D, PHD
Neurology — Payments: $9,443
Karen Aquino, M.d, M.D
Neurology — Payments: $9,199
Dr. Jindong Xu, Md, MD
Neurology — Payments: $8,447